Abstract:Background & Aims: The mechanism underlying resistance to immunotherapy involves engagement of immune checkpoint pathways. The transcriptional and epigenetic processes of checkpoint molecules, however, have not been well investigated. We thus studied whether the transcription factor myeloid zinc finger 1 (MZF1) may promote resistance to immunotherapy in hepatocellular carcinoma (HCC). Methods: Single-cell RNA-sequencing was performed to study the correlation between MZF1 and tumour microenvironment features in six patients with HCC. Combined immunohistochemistry and multi-immunofluorescence analyses were per-formed for verification. Ectopic expression of MZF1 was used in both orthotopic and genetically engineered hydrodynamic mouse HCC models for in vivo experiments. Proteome analysis, including protein degradation assays, ubiquitination assays, and co-immunoprecipitation assays, revealed the function of MZF1 in immune checkpoint pathways. Results: Single-cell RNA-sequencing suggested an immunosuppressive environment and a strong correlation with the im-mune checkpoint programmed death ligand 1 (PD-L1) in MZF1-overexpressing tumours. Analyses of 163 HCC samples demonstrated that MZF1 expression in HCC cells is associated with decreased T-cell infiltration. In vivo experiments showed that ectopic MZF1 expression in HCC cells impairs T-cell recruitment, resulting in resistance to immune checkpoint blockade. Mechanistically, MZF1 accelerated PD-L1 ubiquitination by binding to the cyclin-dependent kinase 4 (CDK4) activation site, while a direct bond between CDK4 and MZF1 led to increased MZF1 expression. Conclusions: MZF1 promotes PD-L1 ubiquitination via CDK4 and possibly MZF1. Inhibition of CDK4 can therefore restore PD -L1 expression and may be a potential strategy for combination with anti-PD-L1 antibodies. Impact and implications: Resistance to immune checkpoint blockade with anti-programmed death ligand 1 (PD-L1) anti-body therapy is attributed to oncogenic alterations of tumour cells, however, effective countermeasures are yet to be established. Here, we report that the transcription factor myeloid zinc finger 1 (MZF1) can bind to the cyclin-dependent kinase 4 (CDK4) activation site and accelerate PD-L1 ubiquitination. A CDK4 inhibitor therefore enhances anti-PD-L1 anti-body efficacy by blocking MZF1 signalling. This indicates a potential benefit of combining CDK4 inhibitors and anti-PD-L1 antibodies for the treatment of advanced HCC. (c) 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A

Forced Over-Expression of the Myeloid Zinc Finger Gene MZF-1 Inhibits Apoptosis and Promotes Oncogenesis in Interleukin-3-dependent FDCP.1 Cells.

Correction: MZF1 mediates oncogene-induced senescence by promoting the transcription of p16 INK4A

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

SENP1 Is a Crucial Regulator for Cell Senescence through DeSUMOylation of Bmi1

Zeb1-Induced Tumourigenesis Requires Senescence Inhibition Via Activation of Dkk1/Mutant P53/Mdm2/Ctbp and Repression of Macroh2a1

PIM1-catalyzed CBX8 Phosphorylation Promotes the Oncogene-Induced Senescence of Human Diploid Fibroblast.

FOXA1 Mediates P16ink4a Activation During Cellular Senescence

FOXA1 mediates p16(INK4a) activation during cellular senescence.

MZF1 Upregulation Mediates Ionizing Radiation-Induced Senescence of Cardiovascular Cells via Regulating NEO1

Transcriptional factor HBP1 targets P16 INK4A , upregulating its expression and consequently is involved in Ras-induced premature senescence

HBP1-mediated Regulation of P21 Protein Through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis

Induction of P38δ Expression Plays an Essential Role in Oncogenic Ras-Induced Senescence

Suppression of RAD21 Induces Senescence of MDA‐MB‐231 Human Breast Cancer Cells Through RB1 Pathway Activation Via C‐myc Downregulation

The ZEB1 Transcription Factor Acts in a Negative Feedback Loop with Mir200 Downstream of Ras and Rb1 to Regulate Bmi1 Expression

Enhancer of Zeste Homolog 2 Depletion Induces Cellular Senescence Via Histone Demethylation along the Ink4/Arf Locus

Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation

Protein kinase D1 phosphorylates CBX8 to facilitate the disassociation of PRC1 complex from p16 promoter and promotes cell senescence

Sequential Inductions of the ZEB1 Transcription Factor Caused by Mutation of Rb and then Ras Proteins Are Required for Tumor Initiation and Progression

DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence.

MZF1 Promotes Tumour Progression and Resistance to Anti-Pd-l1 Antibody Treatment in Hepatocellular Carcinoma